Christiana E. Toomey

B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma

Matija Snuderl, Olga Kolman, Yi‐Bin Chen et al. · The American Journal of Surgical Pathology · 2010 · 355 citations · Full text

Medicine, Hematology, Pathology +17

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma

Jeremy S. Abramson, Matthew D. Hellmann, Jeffrey A. Barnes et al. · Cancer · 2010 · 236 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

Jeffrey A. Barnes, Ann S. LaCasce, Yang Feng et al. · Annals of Oncology · 2011 · 149 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma

Jeffrey A. Barnes, Ann S. LaCasce, Katherine Zukotynski et al. · Annals of Oncology · 2010 · 105 citations · Full text

Medicine, Oncology, Radiology +13

A Patient Death Attributable to Implant-Related Primary Anaplastic Large Cell Lymphoma of the Breast

Matthew J. Carty, Julian J. Pribaz, Joseph H. Antin et al. · Plastic & Reconstructive Surgery · 2011 · 97 citations

Medicine, Oncology, Surgery +8